Goldman Sachs Group »

Unicycive Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $47k 93k 0.50
2024-03-31 $129k 93k 1.38
2023-12-31 $81k 93k 0.87
2023-09-30 $80k 93k 0.86
2023-06-30 $123k 96k 1.28